Nitric Oxide Management Market Receives Major Impetus amid the COVID-19 Pandemic: Fact.MR Study

Proven inhibitory impacts of nitric oxide on the SARS-CoV-2 synthesis and proliferation has spiked demand for nitric oxide management devices

Fact.MR, Rockville: Award winning market research company Fact.MR is conducting an exhaustive study on the global nitric oxide management market. As per this study, the market is likely witness healthy expansion in 2021, registering a strong annual growth figure, attributed to rising applications in treating various respiratory and pulmonary ailments. Long-term growth prospects also appear positive, with a steady CAGR projected in the upcoming decade.

The market made significant gains in the historical period, with popularity especially surging amid the COVID-19 pandemic crisis. Several clinical studies have established the pivotal role played by nitric oxide in mitigating the debilitating vascular and cardiopulmonary impacts induced by the SARS-CoV-2. The National Center for Biotechnology Information has concluded that nitric oxide induces mild bronchodilation and inhibits neutrophil mediated oxidative bursts.

The sudden outbreak of COVID-19 led to an inundation of hospitals and healthcare settings with respect to providing treatment to infected patients. A high percentage of mechanically ventilated patients developed multiple organ failure, leading to high mortality rates. Those who survived required prolonged hospitalization, hence requiring constant maintenance and care, which led to a spike in demand for nitric oxide management systems, a trend which is not likely to wane in the future.

“As the population across the globe expands, demand for quality healthcare services are expected to register an upward sloping curve, prompting manufacturers to enhance their supply of nitric oxide management systems to address a broad spectrum of chronic and infectious ailments,” says the Fact.MR analyst.

Request a report sample to gain valuable insights at

Key Takeaways from the Nitric Oxide Management Study

  • Demand for portable nitric oxide management systems is bound to aggrandize, attributed to the rising demand for mobile solutions
  • Hospitals to remain primary end-users, demand across homecare settings to eventually burgeon
  • U.S to generate credible revenue opportunities, attributed to rising cases of respiratory disorders
  • U.K to witness steady annual expansion, owing to increased uptake following the pandemic crisis
  • France and Germany to register positive growth amid heightened research in advancing medical care
  • Growing prevalence of neonatal pulmonary hypertension to heighten adoption across the Asian markets

Nitric Oxide Management Market- Prominent Drivers

  • Rising number of pediatric cardiopulmonary bypass surgeries and neonatal pulmonary hypertension is widening the berth for nitric oxide management systems
  • Cost-effectiveness and easy fabrication of auxiliary holding devices with main ventilation units makes it an ideal choice, heightening growth prospects
  • Manufacturers are leveraging smart technologies to develop highly advanced nitric oxide management systems such as AI and ML to facilitate precision based treatment

Nitric Oxide Management Market- Key Restraints

  • Inadequate reimbursement policies by governments are leading to supply bottlenecks, expected to act as a deterrent to market growth

Discover more about the nitric oxide management market with figures, data tables and the table of contents. You will also find detailed market segmentation on

Competitive Landscape

Bellerophon Therapeutics, BOC Healthcare, Dan Hammer Health Ltd., EKU Elektronik GmbH, GeNO LLC, International Biomedical, SLE, Mallinckrodt Pharmaceuticals, Praxair, Inc. and Vapothermand are some prominent players profiled in Fact.MR’s ongoing nitric oxide management market study. These players emphasize on introducing next generation management systems to provide precision based and effective treatment.

Dan Hammer Health Ltd., for instance, offers the L-Arginine Pathway therapy to facilitate creation of nitric oxide. Combined with l-citrulline, it enhances the ability of the endothelium to produce high levels of nitric oxide over long time periods. It can also be combined with the ProAgri-9+ to facilitate the same.

Likewise, International Biomedical manufactures the AeroNOx 2.0 Nitric Oxide Delivery System which provides a controlled concentration of nitric oxide by delivering a constant flow into the inspiratory limb of a mechanical ventilator. The device facilitates real-time monitoring with incredible precision, and a continuous monitoring of oxides via side-stream analysis.

More Insights on the Nitric Oxide Management Market

In its latest report, Fact.MR offers unbiased analysis of the global nitric oxide management market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (portable systems and fixed systems) and end-user (hospitals, ambulatory surgical centers, homecare and clinics) across five major regions of the world (North America, Latin America, Europe, Asia Pacific and MEA).

Explore Fact.MR’s Coverage on the Healthcare Domain

PCR and Real Time PCR Molecular Diagnostics Market: A report by Fact.MR on the PCR and real-time PCR molecular diagnostics market provides a 10-year forecast analysis for the period of 2020 to 2030. The study covers key trends that are influencing the growth including the drivers, restraints, and opportunities for leading market players.

Equine Diagnostic Services Market: A detailed assessment of equine diagnostic services value chain analysis, business execution, and supply chain analysis across regional markets has been covered in Fact.MR’s exhaustive equine diagnostic services market. This report discusses vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders and new players.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Back to news